Development of targeting lonidamine liposomes that circumvent drug-resistant cancer by acting on mitochondrial signaling pathways. (Q39194384)
Jump to navigation
Jump to search
scientific article published on 11 February 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Development of targeting lonidamine liposomes that circumvent drug-resistant cancer by acting on mitochondrial signaling pathways. |
scientific article published on 11 February 2013 |
Statements
Development of targeting lonidamine liposomes that circumvent drug-resistant cancer by acting on mitochondrial signaling pathways (English)
Nan Li
Cheng-Xiang Zhang
Xiao-Xing Wang
Liang Zhang
Xu Ma
Rui-Jun Ju
Xiu-Ying Li
Wei-Yu Zhao
11 February 2013